Rationale for the Development and the Mechanism of Action of Endoscopic Thermal Vapor Ablation (InterVapor) for the Treatment of Emphysema
- 1 July 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Bronchology & Interventional Pulmonology
- Vol. 19 (3), 237-245
- https://doi.org/10.1097/lbr.0b013e31826137bc
Abstract
Emphysema remains a disabling disease despite current treatment. Novel approaches to the underlying physiological abnormalities responsible for symptom generation are warranted. A review of current hypotheses and preclinical and clinical data on the utility of endoscopic thermal vapor ablation (InterVapor) in the treatment of emphysema. In animal studies, thermal energy in the form of heated water vapor both in healthy and in papain-induced emphysema in dogs and sheep leads to an inflammatory response followed by healing with airway and parenchymal fibrosis. The fibrosis and associated distal atelectasis result in volume reduction. The amount of thermal energy delivered has been based on the amount of target tissue mass determined from a high-resolution computed tomogram. Early human studies indicated the feasibility of InterVapor with 5 cal/g tissue; however, the dose appeared insufficient to induce lobar volume reduction. A study using 10 cal/g to 1 upper lobe (n=44) induced a mean of 46% lobar volume reduction at 12 months along with significant improvements in the physiology and health outcomes. InterVapor induces lung volume reduction in patients with emphysema. The mechanism of action is through a thermally induced inflammatory response followed by healing with subsequent remodeling of tissue (fibrosis and distal atelectasis).Keywords
This publication has 17 references indexed in Scilit:
- The National Emphysema Treatment Trial (NETT)American Journal of Respiratory and Critical Care Medicine, 2011
- Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trialThe Lancet, 2011
- A Randomized Study of Endobronchial Valves for Advanced EmphysemaThe New England Journal of Medicine, 2010
- Lung Volume Reduction Therapies for Advanced EmphysemaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- A Multicenter Pilot Study of a Bronchial Valve for the Treatment of Severe EmphysemaRespiration, 2009
- Clinical application of airway bypass with paclitaxel-eluting stents: Early resultsThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical Therapy for Severe Emphysema by the National Emphysema Treatment Trial Research GroupThe Annals of Thoracic Surgery, 2006
- Measurement of Symptoms, Lung Hyperinflation, and Endurance during Exercise in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Exertional Breathlessness in Patients with Chronic Airflow Limitation: The Role of Lung HyperinflationAmerican Review of Respiratory Disease, 1993